Tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC): Interim analysis of VISION cohorts A and C Meeting Abstract
| Authors: | Griesinger, F.; Thomas, M.; Reinmuth, N.; Wermke, M.; Overbeck, T.; Alt, J.; Henschke, S.; Wehler, T.; Ochsenreither, S.; Garassino, M. C.; Felip, E.; Sakai, H.; Bruns, R.; Otto, G.; Johne, A.; Paik, P. K. |
| Abstract Title: | Tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC): Interim analysis of VISION cohorts A and C |
| Meeting Title: | 2022 Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 45 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2022 Nov 13-16 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2022-11-01 |
| Start Page: | 153 |
| Language: | English |
| ACCESSION: | WOS:000883051700359 |
| PROVIDER: | wos |
| DOI: | 10.1159/000521004 |
| Notes: | Meeting Abstract: 370 -- Source: Wos |
